Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2013

01-03-2013 | Review Article

Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality?

Authors: Katia Lofano, Mariabeatrice Principi, Maria Principia Scavo, Maria Pricci, Enzo Ierardi, Alfredo Di Leo

Published in: Journal of Gastrointestinal Cancer | Issue 1/2013

Login to get access

Abstract

Background and Purpose

Interest in the possibility that diet might help to reduce the risk of colorectal cancer dates back to 1970 based on both the large variation in rates of specific cancers in different countries and the impressive changes observed in the incidence of cancer in migrants from low- to high-risk areas. Here, we report the state of art of literature data about this topic.

Methods

Three sections have been separately considered: chemoprevention of first tumor onset, chemoprevention of recurrence after surgery, and chemoprevention of polyp recurrence in the course of the follow-up of subjects with elevated risk. A particular attention has been pointed to dietary factors and survival, whose relevance is showing a growing interest.

Results

The relationship between diet and colorectal cancer has been extensively studied about the onset, sometimes with controversial results. Its influence on recurrence and survival has been examined in only few studies.

Conclusions

Literature data are convincing for a protective role on the onset of preneoplastic and neoplastic lesions for some foods such as fibers, vitamin A and D, folic acid, calcium, antioxidants, and promising perspectives for some substances such as phyto-estrogens. Less evidence-based data are available on the possibility to avoid the recurrence of the disease or to affect its mortality with dietary habits. Future perspectives will be directed be not only to identify new dietary style able to prevent the onset of neoplastic lesion of the colon but also to realize an effective chemoprevention.
Literature
1.
go back to reference Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(1):148–58.PubMedCrossRef Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(1):148–58.PubMedCrossRef
2.
go back to reference Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15(4):617–31.PubMedCrossRef Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15(4):617–31.PubMedCrossRef
3.
go back to reference Burkitt DP. Possible relationship between bowel cancer and dietary habits. Pro R Soc Med. 1971;64(9):964–5. Burkitt DP. Possible relationship between bowel cancer and dietary habits. Pro R Soc Med. 1971;64(9):964–5.
4.
go back to reference Beliveau R, Gingras D. Role of nutrition in preventing cancer. Can Fam Physician. 2007;53(11):1905–11.PubMed Beliveau R, Gingras D. Role of nutrition in preventing cancer. Can Fam Physician. 2007;53(11):1905–11.PubMed
5.
go back to reference Michels KB, Fuchs CS, Giovannucci E, et al. Fiber intake and incidence of colorectal cancer among 76.947 women and 47.279 men. Canc Epidemiol Biomarkers Prev. 2005;14:842–9.CrossRef Michels KB, Fuchs CS, Giovannucci E, et al. Fiber intake and incidence of colorectal cancer among 76.947 women and 47.279 men. Canc Epidemiol Biomarkers Prev. 2005;14:842–9.CrossRef
6.
go back to reference Macrae F. Wheat brean fiber and development of adenomatous polyps evidence from randomized, controlled clinical trials. Am J Med. 1999;106(1A):38S–42S.PubMedCrossRef Macrae F. Wheat brean fiber and development of adenomatous polyps evidence from randomized, controlled clinical trials. Am J Med. 1999;106(1A):38S–42S.PubMedCrossRef
8.
go back to reference Wiseman M. The second Word Cancer Research Fund/American Institute for Cancer Research exper report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.PubMedCrossRef Wiseman M. The second Word Cancer Research Fund/American Institute for Cancer Research exper report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.PubMedCrossRef
9.
go back to reference World Health Organization. Diet Nutrition and the prevention of chronic disease. Report of a Joint FAO/WHO Expert Consultation. WHO Technical Report Series. 2003, No916. World Health Organization. Diet Nutrition and the prevention of chronic disease. Report of a Joint FAO/WHO Expert Consultation. WHO Technical Report Series. 2003, No916.
10.
go back to reference Linseisen J, Rohrmann S, Miller AB, et al. Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2007;121(5):1103–14.PubMedCrossRef Linseisen J, Rohrmann S, Miller AB, et al. Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2007;121(5):1103–14.PubMedCrossRef
11.
go back to reference Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. Dietary fiber and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294(22):2849–57.PubMedCrossRef Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. Dietary fiber and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294(22):2849–57.PubMedCrossRef
12.
go back to reference Nomura AM, Wilkens LR, Murphy SP, et al. Association of vegetable, fruit and grain intakes with colorectal cancer: the Multiethnic Cohort Study. Am J Clin Nutr. 2008;88(3):730–7.PubMed Nomura AM, Wilkens LR, Murphy SP, et al. Association of vegetable, fruit and grain intakes with colorectal cancer: the Multiethnic Cohort Study. Am J Clin Nutr. 2008;88(3):730–7.PubMed
13.
go back to reference Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr. 2007;85(5):1353–60.PubMed Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr. 2007;85(5):1353–60.PubMed
14.
go back to reference Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat diet pattern and risk of colorectal cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):643–54.PubMedCrossRef Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat diet pattern and risk of colorectal cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):643–54.PubMedCrossRef
15.
go back to reference Satia-Abouta J, Galanko JA, Martin CF, Ammerman A, Sandler RS. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer. 2004;109:728–36.PubMedCrossRef Satia-Abouta J, Galanko JA, Martin CF, Ammerman A, Sandler RS. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer. 2004;109:728–36.PubMedCrossRef
16.
go back to reference Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997;66:1564–71. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997;66:1564–71.
17.
go back to reference Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case–control studies. Canc Causes Contr. 1997;8:215–28.CrossRef Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case–control studies. Canc Causes Contr. 1997;8:215–28.CrossRef
18.
go back to reference Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case–control study. Int J Epidemiol. 2003;32:200–9.PubMedCrossRef Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case–control study. Int J Epidemiol. 2003;32:200–9.PubMedCrossRef
19.
go back to reference Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al. Dietary fatty acids and colorectal cancer: a case–control study. Am J Epidemiol. 2007;166:181–95.PubMedCrossRef Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al. Dietary fatty acids and colorectal cancer: a case–control study. Am J Epidemiol. 2007;166:181–95.PubMedCrossRef
20.
go back to reference Lin J, Zhang SM, Cook NR, Lee IM, Buring JE. Dietary fat and fatty acids and risk of colorectal cancer in women. Am J Epidemiol. 2004;160:1011–22.PubMedCrossRef Lin J, Zhang SM, Cook NR, Lee IM, Buring JE. Dietary fat and fatty acids and risk of colorectal cancer in women. Am J Epidemiol. 2004;160:1011–22.PubMedCrossRef
21.
go back to reference MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.PubMedCrossRef MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.PubMedCrossRef
22.
go back to reference Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD. Trans-fatty acids and colon cancer. Nutr Cancer. 2001;39:170–5.PubMedCrossRef Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD. Trans-fatty acids and colon cancer. Nutr Cancer. 2001;39:170–5.PubMedCrossRef
23.
go back to reference Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM. Ciclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res. 2003;62(23):6846–9. Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM. Ciclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res. 2003;62(23):6846–9.
24.
go back to reference Takeda M, Sonoshita M, Oshima H, Saugihara K, Chulad PC, Langenbach R, et al. Cooperation of cyclooxigenase 1 and cyclooxigenase 2 in intestinal polyps. Cancer Res. 2003;63(16):4872–7.PubMed Takeda M, Sonoshita M, Oshima H, Saugihara K, Chulad PC, Langenbach R, et al. Cooperation of cyclooxigenase 1 and cyclooxigenase 2 in intestinal polyps. Cancer Res. 2003;63(16):4872–7.PubMed
25.
go back to reference Kargman SL, O’Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancers. Cancer Res. 1995;55(12):2556–9.PubMed Kargman SL, O’Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancers. Cancer Res. 1995;55(12):2556–9.PubMed
26.
go back to reference Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxigenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183–8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxigenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183–8.
27.
go back to reference Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Muhai S, Kimura S, et al. Expression of cyclooxigenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55(17):3785–9.PubMed Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Muhai S, Kimura S, et al. Expression of cyclooxigenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55(17):3785–9.PubMed
28.
go back to reference Chan TA. Cyclooxigenase inhibition and mechanisms of colorectal cancer prevention. Curr Cancer Drug Targets. 2003;3(6):455–63.PubMedCrossRef Chan TA. Cyclooxigenase inhibition and mechanisms of colorectal cancer prevention. Curr Cancer Drug Targets. 2003;3(6):455–63.PubMedCrossRef
29.
go back to reference Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K. Combined effects of cyclooxigenase -1 and cyclooxigenase -2 selective inhibitors on intestinal tumorigenesis in adenomatous polyps coli gene knockout mice. Int J Cancer. 2004;109:576–80.PubMedCrossRef Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K. Combined effects of cyclooxigenase -1 and cyclooxigenase -2 selective inhibitors on intestinal tumorigenesis in adenomatous polyps coli gene knockout mice. Int J Cancer. 2004;109:576–80.PubMedCrossRef
30.
go back to reference Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomized trials. Lancet. 2004;376:1741–50.CrossRef Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomized trials. Lancet. 2004;376:1741–50.CrossRef
31.
go back to reference Sanderson P, Johnson IT, Mathers JC, et al. Emerging diet-related surrogate end points for colorectal cancer: UK Food Standards Agency diet and colonic health workshop report. Br J Nutr. 2004;91:315–23.PubMedCrossRef Sanderson P, Johnson IT, Mathers JC, et al. Emerging diet-related surrogate end points for colorectal cancer: UK Food Standards Agency diet and colonic health workshop report. Br J Nutr. 2004;91:315–23.PubMedCrossRef
32.
go back to reference Frommel TO, Dyavanapalli M, Oldham T, et al. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients. Clin Cancer Res. 1997;3:209–13.PubMed Frommel TO, Dyavanapalli M, Oldham T, et al. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients. Clin Cancer Res. 1997;3:209–13.PubMed
33.
go back to reference Demeyer D, Honikel K, De Smet S. The World Cancer Research Fund report 2007: a challenge for the meat processing industry. Meat Sci. 2008;80(4):953–9.PubMedCrossRef Demeyer D, Honikel K, De Smet S. The World Cancer Research Fund report 2007: a challenge for the meat processing industry. Meat Sci. 2008;80(4):953–9.PubMedCrossRef
34.
go back to reference Larsson SC, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer. 2006;119(11):2657–64.PubMedCrossRef Larsson SC, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer. 2006;119(11):2657–64.PubMedCrossRef
35.
go back to reference Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose–response meta-analysis of epidemiological studies. Int J Cancer. 2002;98(2):241–56.PubMedCrossRef Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose–response meta-analysis of epidemiological studies. Int J Cancer. 2002;98(2):241–56.PubMedCrossRef
36.
go back to reference Sandhu M, White I, Mcpherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Canc Epidemiol Biomarkers Prev. 2001;10:439–46. Sandhu M, White I, Mcpherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Canc Epidemiol Biomarkers Prev. 2001;10:439–46.
37.
go back to reference Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008;60(2):131–44.PubMedCrossRef Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008;60(2):131–44.PubMedCrossRef
38.
go back to reference Bingham SA, Pignatelli B, Pollock JRA, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis. 1996;17(3):515–23.PubMedCrossRef Bingham SA, Pignatelli B, Pollock JRA, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis. 1996;17(3):515–23.PubMedCrossRef
39.
go back to reference Lunn JC, Kuhnle G, Mai V, et al. The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract. Carcinogenesis. 2007;28(3):685–90.PubMedCrossRef Lunn JC, Kuhnle G, Mai V, et al. The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract. Carcinogenesis. 2007;28(3):685–90.PubMedCrossRef
40.
go back to reference Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 2004;95(4):290–9.PubMedCrossRef Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 2004;95(4):290–9.PubMedCrossRef
41.
go back to reference Sinha R, Rothman N, Brown ED, et al. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res. 1995;55(20):4516–9.PubMed Sinha R, Rothman N, Brown ED, et al. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res. 1995;55(20):4516–9.PubMed
42.
go back to reference Stavric B. Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Food Chem Toxicol. 1994;32(10):977–94.PubMedCrossRef Stavric B. Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Food Chem Toxicol. 1994;32(10):977–94.PubMedCrossRef
43.
go back to reference Sesink ALA, Termont DSML, Kleibeuker JH, Vandermeer R. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res. 1999;59(22):5704–9.PubMed Sesink ALA, Termont DSML, Kleibeuker JH, Vandermeer R. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res. 1999;59(22):5704–9.PubMed
44.
go back to reference Pierre F, Freeman A, Tache S, Van der Meer R, Corpet DE. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr. 2004;134(10):2711–6.PubMed Pierre F, Freeman A, Tache S, Van der Meer R, Corpet DE. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr. 2004;134(10):2711–6.PubMed
45.
go back to reference Pierre F, Santarelli R, Tache S, Gueraud F, Corpet DE. Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium. Br J Nutr. 2008;99(5):1000–6.PubMedCrossRef Pierre F, Santarelli R, Tache S, Gueraud F, Corpet DE. Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium. Br J Nutr. 2008;99(5):1000–6.PubMedCrossRef
46.
go back to reference Pierre F, Tache S, Petit CR, Van der Meer R, Corpet DE. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24(10):1683–90.PubMedCrossRef Pierre F, Tache S, Petit CR, Van der Meer R, Corpet DE. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24(10):1683–90.PubMedCrossRef
47.
go back to reference Lubin F, Rozen P, Arieli B, Farbstein M, Knaani Y, Bat L, et al. Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev. 1997;6(2):79–85.PubMed Lubin F, Rozen P, Arieli B, Farbstein M, Knaani Y, Bat L, et al. Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev. 1997;6(2):79–85.PubMed
48.
go back to reference Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999;15(6):523–6.PubMedCrossRef Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999;15(6):523–6.PubMedCrossRef
50.
go back to reference Weijenberg MP, Mullie PF, Brants HA, Heinen MM, Goldbohm RA, van den Brandt PA. Dietary glicemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study. Int J Cancer. 2008;122(3):620–9.PubMedCrossRef Weijenberg MP, Mullie PF, Brants HA, Heinen MM, Goldbohm RA, van den Brandt PA. Dietary glicemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study. Int J Cancer. 2008;122(3):620–9.PubMedCrossRef
51.
go back to reference Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–7.PubMedCrossRef Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–7.PubMedCrossRef
52.
go back to reference Levine AJ, Harper JM, Ervin CM, et al. Serum 25-hydroxyvitaminD, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 2001;39:35–41.PubMedCrossRef Levine AJ, Harper JM, Ervin CM, et al. Serum 25-hydroxyvitaminD, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 2001;39:35–41.PubMedCrossRef
53.
go back to reference Peters U, Mc Glynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001;10:1267–74.PubMed Peters U, Mc Glynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001;10:1267–74.PubMed
54.
go back to reference Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 2000;60:2304–12.PubMed Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 2000;60:2304–12.PubMed
55.
go back to reference Lappe JMT. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–91.PubMed Lappe JMT. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–91.PubMed
56.
go back to reference Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O’Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–96.PubMedCrossRef Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O’Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–96.PubMedCrossRef
57.
go back to reference Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J, Bonithon-Kopp C, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000;356:1300–6.PubMedCrossRef Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J, Bonithon-Kopp C, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000;356:1300–6.PubMedCrossRef
58.
go back to reference Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group. Ann N Y Acad Sci. 1999;889:138–45.PubMedCrossRef Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group. Ann N Y Acad Sci. 1999;889:138–45.PubMedCrossRef
59.
go back to reference Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005;14(2):525–8.PubMedCrossRef Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005;14(2):525–8.PubMedCrossRef
60.
go back to reference Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2001;132:2413–8. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2001;132:2413–8.
61.
go back to reference Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51:267–92.PubMedCrossRef Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51:267–92.PubMedCrossRef
62.
go back to reference Stevens VL, McCullough ML, Sun J, Jacobs EJ, Campbell PT, Gapstur SM. High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology. 2011;141:98–105.PubMedCrossRef Stevens VL, McCullough ML, Sun J, Jacobs EJ, Campbell PT, Gapstur SM. High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology. 2011;141:98–105.PubMedCrossRef
63.
go back to reference Cole BF, Baron JA, Sandler RS, et al. Polyp prevention study group: folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–9.PubMedCrossRef Cole BF, Baron JA, Sandler RS, et al. Polyp prevention study group: folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–9.PubMedCrossRef
64.
go back to reference Sie KK, Medline A, van Wee lJ, Sohn KJ, Choi SW, Croxford R, et al. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the off spring. Gut. 2011;60:1687–94.PubMedCrossRef Sie KK, Medline A, van Wee lJ, Sohn KJ, Choi SW, Croxford R, et al. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the off spring. Gut. 2011;60:1687–94.PubMedCrossRef
65.
go back to reference Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther. 2008;28:689–703.PubMedCrossRef Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther. 2008;28:689–703.PubMedCrossRef
66.
go back to reference Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008; Issue 4, Art No. CD004183. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008; Issue 4, Art No. CD004183.
67.
go back to reference Gingras D, Bèliveau R. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenvir. 2011;4:133–9.CrossRef Gingras D, Bèliveau R. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenvir. 2011;4:133–9.CrossRef
68.
go back to reference Yang G. Prospective cohort study of soy-food intake and colorectal cancer risk in women. Am J Clin Nutr. 2009;89:577–83.PubMedCrossRef Yang G. Prospective cohort study of soy-food intake and colorectal cancer risk in women. Am J Clin Nutr. 2009;89:577–83.PubMedCrossRef
69.
go back to reference Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogens intake is associated with reduced colorectal cancer risk. J Nutr. 2006;136:3046–53.PubMed Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogens intake is associated with reduced colorectal cancer risk. J Nutr. 2006;136:3046–53.PubMed
70.
go back to reference Flood DM, Weiss NS, Cook LS, Emerson JC, Schwartz SM, Potter JD. Colorectal cancer incidence in Asian migrants to the United states and their descendants. Canc Causes Control. 2000;11(5):403–11.CrossRef Flood DM, Weiss NS, Cook LS, Emerson JC, Schwartz SM, Potter JD. Colorectal cancer incidence in Asian migrants to the United states and their descendants. Canc Causes Control. 2000;11(5):403–11.CrossRef
71.
go back to reference Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol. 2010;25(1):33–42.PubMedCrossRef Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol. 2010;25(1):33–42.PubMedCrossRef
72.
go back to reference Kostantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor’s dedifferentiation. Eur J Cancer. 2003;39(9):1251–8.CrossRef Kostantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor’s dedifferentiation. Eur J Cancer. 2003;39(9):1251–8.CrossRef
73.
go back to reference Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon; potential mechanisms for cancer prevention. Lancet oncol. 2008;9(4):385–91.PubMedCrossRef Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon; potential mechanisms for cancer prevention. Lancet oncol. 2008;9(4):385–91.PubMedCrossRef
74.
go back to reference Gingras D, Bèliveau R. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenvir. 2011;4:133–9.CrossRef Gingras D, Bèliveau R. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenvir. 2011;4:133–9.CrossRef
75.
go back to reference Turner JV, Agatonovi-Kustrin S, Glass BD. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci. 2007;96(8):1879–85.PubMedCrossRef Turner JV, Agatonovi-Kustrin S, Glass BD. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci. 2007;96(8):1879–85.PubMedCrossRef
76.
go back to reference Budhathoki S, Joshi AM, Ohnaka K, et al. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka colorectal cancer study. Scand J Gastroenterol. 2011;201(46):165–72.CrossRef Budhathoki S, Joshi AM, Ohnaka K, et al. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka colorectal cancer study. Scand J Gastroenterol. 2011;201(46):165–72.CrossRef
77.
go back to reference Lechner D, Kallay E, Cross HS. Phytoestrogens and colorectal cancer prevention. Vitamins Horm. 2005;70:169–98.CrossRef Lechner D, Kallay E, Cross HS. Phytoestrogens and colorectal cancer prevention. Vitamins Horm. 2005;70:169–98.CrossRef
78.
go back to reference Kuijsten A, Arts IC, Hollman PC, van’t Veer P, Kampman E. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1132–6.PubMedCrossRef Kuijsten A, Arts IC, Hollman PC, van’t Veer P, Kampman E. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1132–6.PubMedCrossRef
79.
go back to reference Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European prospective into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2891–4.PubMedCrossRef Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European prospective into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2891–4.PubMedCrossRef
80.
go back to reference Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, et al. Dietary induced ERβ up-regulation counteracts intestinal neoplasia development in intacte male ApcMin/+ mice. Carcinogenesis. 2010;31(2):269–74.PubMedCrossRef Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, et al. Dietary induced ERβ up-regulation counteracts intestinal neoplasia development in intacte male ApcMin/+ mice. Carcinogenesis. 2010;31(2):269–74.PubMedCrossRef
81.
go back to reference Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-e-low folate diets and risk of colon cancer in men. J Natl Cancer Inst. 1995;87(4):265–73.PubMedCrossRef Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-e-low folate diets and risk of colon cancer in men. J Natl Cancer Inst. 1995;87(4):265–73.PubMedCrossRef
82.
go back to reference Seitz HK, Simanowski UA, Homann N, Waldherr R. Cell proliferation and its evaluation in the colorectal mucosa: effect of ethanol. Z Gastroenterol. 1998;36(8):645–55.PubMed Seitz HK, Simanowski UA, Homann N, Waldherr R. Cell proliferation and its evaluation in the colorectal mucosa: effect of ethanol. Z Gastroenterol. 1998;36(8):645–55.PubMed
83.
go back to reference Davis CD, Milner JA. Gastrointestinal microflora, food componence and colon cancer prevention. J Nutr Biochem. 2009;20(10):743–52.PubMedCrossRef Davis CD, Milner JA. Gastrointestinal microflora, food componence and colon cancer prevention. J Nutr Biochem. 2009;20(10):743–52.PubMedCrossRef
84.
go back to reference Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc. 2003;103:323–8.PubMed Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc. 2003;103:323–8.PubMed
85.
go back to reference Satia JA, Campbell MK, Galanko JA, JamesA CC, Sandler RS. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev. 2004;13:1022–31.PubMed Satia JA, Campbell MK, Galanko JA, JamesA CC, Sandler RS. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev. 2004;13:1022–31.PubMed
86.
go back to reference Reedy J, Haines PS, Steckler A, Campbell MK. Qualitative comparison of dietary choices and dietary supplement use among older adults with and without a history of colorectal cancer. J Nutr Educ Behav. 2005;37:252–8.PubMedCrossRef Reedy J, Haines PS, Steckler A, Campbell MK. Qualitative comparison of dietary choices and dietary supplement use among older adults with and without a history of colorectal cancer. J Nutr Educ Behav. 2005;37:252–8.PubMedCrossRef
87.
go back to reference Slattery ML, French TK, Egger MJ, Lyon JL. Diet and survival of patients with colon cancer in Utah: is there an association? Int J Epidemiol. 1989;18:792–7.PubMedCrossRef Slattery ML, French TK, Egger MJ, Lyon JL. Diet and survival of patients with colon cancer in Utah: is there an association? Int J Epidemiol. 1989;18:792–7.PubMedCrossRef
88.
go back to reference Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017–24.PubMedCrossRef Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017–24.PubMedCrossRef
89.
go back to reference Dray X, Boutron-Ruault MC, Bertrais S, Sapinho D, Benhamiche-Bouvier AM, Faivre J. Influence of dietary factors on colorectalcancer survival. Gut. 2003;52:868–73.PubMedCrossRef Dray X, Boutron-Ruault MC, Bertrais S, Sapinho D, Benhamiche-Bouvier AM, Faivre J. Influence of dietary factors on colorectalcancer survival. Gut. 2003;52:868–73.PubMedCrossRef
90.
go back to reference Zell JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H. Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer. 2007;59:36–45.PubMedCrossRef Zell JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H. Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer. 2007;59:36–45.PubMedCrossRef
91.
go back to reference Tian J, Chen ZC, Hang LF. The effects of nutrition status of patients with digestive system cancers on prognosis of the disease. Cancer Nurs. 2008;31:462–7.PubMedCrossRef Tian J, Chen ZC, Hang LF. The effects of nutrition status of patients with digestive system cancers on prognosis of the disease. Cancer Nurs. 2008;31:462–7.PubMedCrossRef
92.
go back to reference Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR. Site specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients:a competing risks survival analysis. Asian Pac J Cancer Prev. 2009;10:815–21.PubMed Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR. Site specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients:a competing risks survival analysis. Asian Pac J Cancer Prev. 2009;10:815–21.PubMed
93.
go back to reference Zell JA, Ignatenko NA, Yerushalmi HF, et al. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumori- genesis and survival. Int J Cancer. 2007;120:459–68.PubMedCrossRef Zell JA, Ignatenko NA, Yerushalmi HF, et al. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumori- genesis and survival. Int J Cancer. 2007;120:459–68.PubMedCrossRef
94.
go back to reference Skeie G, Braaten T, Hjartaker A, Brustad M, Lund E. Cod liver oil, other dietary supplements and survival among cancer patients with solid tumours. Int J Cancer. 2009;12:1155–60.CrossRef Skeie G, Braaten T, Hjartaker A, Brustad M, Lund E. Cod liver oil, other dietary supplements and survival among cancer patients with solid tumours. Int J Cancer. 2009;12:1155–60.CrossRef
95.
go back to reference Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:2984–91.PubMedCrossRef Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:2984–91.PubMedCrossRef
96.
go back to reference Wolpin BM, Wei EK, Ng K, et al. Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol. 2008;26:3222–8.PubMedCrossRef Wolpin BM, Wei EK, Ng K, et al. Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol. 2008;26:3222–8.PubMedCrossRef
97.
go back to reference Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298:754–64.PubMedCrossRef Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298:754–64.PubMedCrossRef
98.
go back to reference Leung EY, Crozier JE, Talwar D, et al. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 2008;123: 2460–4. Leung EY, Crozier JE, Talwar D, et al. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 2008;123: 2460–4.
99.
go back to reference Bystro MP, Bjorkegren K, Larsson A, Johansson L, Berglund A. Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer. Ups J Med Sci. 2009;114:160–4.CrossRef Bystro MP, Bjorkegren K, Larsson A, Johansson L, Berglund A. Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer. Ups J Med Sci. 2009;114:160–4.CrossRef
100.
go back to reference Ng K, Wolpin BM, Meyerhardt JA, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009;101:916–23.PubMedCrossRef Ng K, Wolpin BM, Meyerhardt JA, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009;101:916–23.PubMedCrossRef
101.
go back to reference Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–33.PubMedCrossRef Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–33.PubMedCrossRef
102.
go back to reference Neugut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology. 1995;108:402–8.PubMedCrossRef Neugut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology. 1995;108:402–8.PubMedCrossRef
103.
go back to reference Wegener M, Borsch G, Schmidt G. Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum. 1986;29:383–7.PubMedCrossRef Wegener M, Borsch G, Schmidt G. Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum. 1986;29:383–7.PubMedCrossRef
104.
go back to reference Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag SJ. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol. 2002;97:1524–9.PubMedCrossRef Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag SJ. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol. 2002;97:1524–9.PubMedCrossRef
105.
go back to reference Koushik A, Hunter DJ, Spiegelman D, et al. Fruits, vegetables and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst. 2007;99(19):1471–83.PubMedCrossRef Koushik A, Hunter DJ, Spiegelman D, et al. Fruits, vegetables and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst. 2007;99(19):1471–83.PubMedCrossRef
106.
go back to reference Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat dietary pattern and risk: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):443–52.CrossRef Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat dietary pattern and risk: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):443–52.CrossRef
107.
go back to reference Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med. 2000;342(16):1156–62.PubMedCrossRef Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med. 2000;342(16):1156–62.PubMedCrossRef
108.
go back to reference Schatzin A, Lanza E, Freedman LS, et al. The Polyp Prevention Trial I: rationale, design, recruitment, and baseline partecipants characteristics. Cancer Epidemiol Biomarkers Prev. 1996;5(5):375–83. Schatzin A, Lanza E, Freedman LS, et al. The Polyp Prevention Trial I: rationale, design, recruitment, and baseline partecipants characteristics. Cancer Epidemiol Biomarkers Prev. 1996;5(5):375–83.
109.
go back to reference Sansbury LB, Wanke K, Albert PS, et al. The effect of strict adherence to a high-fiber, high-fruit and -vegetable and low-fat eating pattern on adenoma recurrence. Am J Epidemiol. 2009;170(5):576–84.PubMedCrossRef Sansbury LB, Wanke K, Albert PS, et al. The effect of strict adherence to a high-fiber, high-fruit and -vegetable and low-fat eating pattern on adenoma recurrence. Am J Epidemiol. 2009;170(5):576–84.PubMedCrossRef
110.
go back to reference Methy N, Binquet C, Boutron-Ruault MC, Paillot B, Faivre J, Bonithon-Kopp C. Dietary fatty acids and recurrence of colorectal adenomas in a European interventional trial. Nutr Cancer. 2008;60(5):560–7.PubMedCrossRef Methy N, Binquet C, Boutron-Ruault MC, Paillot B, Faivre J, Bonithon-Kopp C. Dietary fatty acids and recurrence of colorectal adenomas in a European interventional trial. Nutr Cancer. 2008;60(5):560–7.PubMedCrossRef
111.
go back to reference Nakamura T, Ishikawa H, Takeyama I, et al. Excessive fat restriction might promote the recurrence of colorectal adenomas. Nutr Cancer. 2010;62(2):154–63.PubMedCrossRef Nakamura T, Ishikawa H, Takeyama I, et al. Excessive fat restriction might promote the recurrence of colorectal adenomas. Nutr Cancer. 2010;62(2):154–63.PubMedCrossRef
112.
go back to reference Martinez ME, Jacobs ET, Ashbeck EL, et al. Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. Carcinogenesis. 2007;28(9):2019–27.PubMedCrossRef Martinez ME, Jacobs ET, Ashbeck EL, et al. Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. Carcinogenesis. 2007;28(9):2019–27.PubMedCrossRef
113.
go back to reference Mathew A, Sinha R, Burt R, et al. Meat intake and the recurrence of colorectal adenomas. Eur J Cancer Prev. 2004;13(3):159–64.PubMedCrossRef Mathew A, Sinha R, Burt R, et al. Meat intake and the recurrence of colorectal adenomas. Eur J Cancer Prev. 2004;13(3):159–64.PubMedCrossRef
114.
go back to reference Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group [see comment]. N Engl J Med. 1999;340:101–7.PubMedCrossRef Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group [see comment]. N Engl J Med. 1999;340:101–7.PubMedCrossRef
115.
go back to reference Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: A meta-analysis of randomized controlled trials. Am J Gastroenterol. 2005;100:390–4.PubMedCrossRef Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: A meta-analysis of randomized controlled trials. Am J Gastroenterol. 2005;100:390–4.PubMedCrossRef
116.
go back to reference Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–96.PubMedCrossRef Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–96.PubMedCrossRef
117.
go back to reference Greenberg ER, Baron JA, Tosteson TD. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med. 1994;331:141–7.PubMedCrossRef Greenberg ER, Baron JA, Tosteson TD. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med. 1994;331:141–7.PubMedCrossRef
118.
go back to reference Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effects of beta carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 2003;95:717–22.PubMedCrossRef Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effects of beta carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 2003;95:717–22.PubMedCrossRef
119.
go back to reference Steck-Scott S, Forman MR, Sowell A, et al. Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. Int J Cancer. 2004;112(2):295–305.PubMedCrossRef Steck-Scott S, Forman MR, Sowell A, et al. Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. Int J Cancer. 2004;112(2):295–305.PubMedCrossRef
120.
go back to reference Di Leo et al. Dietary Estrogen Receptor β agonists impact proliferative and apoptotic biomarkers in the colon mucosa. A randomized placebo-controlled study. Abstract 19th UEGW 2011. Di Leo et al. Dietary Estrogen Receptor β agonists impact proliferative and apoptotic biomarkers in the colon mucosa. A randomized placebo-controlled study. Abstract 19th UEGW 2011.
Metadata
Title
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality?
Authors
Katia Lofano
Mariabeatrice Principi
Maria Principia Scavo
Maria Pricci
Enzo Ierardi
Alfredo Di Leo
Publication date
01-03-2013
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2013
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-012-9425-y

Other articles of this Issue 1/2013

Journal of Gastrointestinal Cancer 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.